Innovative Clinical Medicine Diagnosis and Treatment Seminar
In order to enhance the awareness of Macau citizens on the prevention and treatment of fatty liver and promote the application of non-invasive liver detection technology in clinical and community settings, the “Innovative Clinical Medicine Diagnosis and Treatment Seminar” hosted by the Macau Health Management and Promotion Association and sponsored by the Macau Foundation was successfully held at the Dr. Stanley Ho Medical Development Foundation in Macau from September 6th to 7th, 2025.
The symposium focused on topics such as the hidden health risks of fatty liver disease, the value of early diagnostic imaging, and new technologies for liver cancer treatment. Professor Zheng Yongping, Chair Professor of Biomedical Engineering at the Hong Kong Polytechnic University, Dr. Huang Zihao, Chief Researcher at Eieling Technology, and several leading medical experts from Guangdong, Hong Kong, and Macao shared their clinical experiences and research findings, offering suggestions for advancing liver disease prevention and treatment in Macao.
Early screening and early diagnosis are the key to breaking the deadlock
As the incidence of liver disease continues to rise worldwide, fatty liver disease has become a significant global public health issue. Due to its insidious onset and lack of obvious early symptoms, many patients remain undetected until they have progressed to the stage of liver fibrosis or even cirrhosis. The importance of early screening and intervention is becoming increasingly prominent. Non-invasive liver testing technology can significantly lower the threshold for liver disease screening, enabling more citizens to detect potential liver disease early and receive standardized treatment.
Zheng Yongping, Chair Professor of the Department of Biomedical Engineering at the Hong Kong Polytechnic University, noted at the conference that liver screening has gradually expanded beyond traditional hospitals to a wider range of settings. “We have conducted numerous large-scale community screenings in mainland China, completing tens of thousands of tests.” Professor Zheng emphasized that “early diagnosis and early treatment” remain the most critical breakthroughs in liver disease prevention and treatment.
Zheng Yongping, Chair Professor of the Department of Biomedical Engineering, Hong Kong Polytechnic University
Dr. Huang Zihao, Chief Researcher of Eieling Technology
Driven by innovation, we will help transform liver disease diagnosis and treatment in Guangdong, Hong Kong and Macao
Leveraging the research strengths of the Hong Kong Polytechnic University, Eieling Technology focuses on liver disease diagnosis and treatment, striving to provide accurate and reliable intelligent liver health diagnostic solutions to healthcare providers worldwide. Through technological innovation, Eieling Technology reshapes liver disease diagnosis and treatment, promoting more accurate and accessible liver screening. Its core product, Liverscan®, integrates transient elastography and real-time ultrasound image guidance into a Wi-Fi-enabled wireless probe, enabling rapid and accurate acquisition of key data such as liver stiffness and steatosis, making it adaptable to a variety of medical and screening scenarios.
Currently, Liverscan® is officially operational at the MMC Center of Kiang Wu Hospital in Macau. Going forward, Eieling will fully support the development of a model hospital in the Guangdong-Hong Kong-Macao Greater Bay Area, further expanding the breadth and depth of its liver health management services and providing Bay Area residents and healthcare professionals with superior, more convenient solutions for early screening and health management of liver disease. Faced with the growing global burden of liver disease, Eieling actively supports the national innovation-driven strategy, continuously promoting the translation of scientific and technological achievements into practical clinical applications, and providing solid technical support for the prevention, control, and treatment of liver disease.
*The above content is from Macau Daily News and Macau Radio and Television